Gene Therapy Applications | Gene Therapy Products | Corning

Fueling What’s Next

Fueling What’s Next

Once considered conceptual, gene therapy is now closer to reality. As gene therapy becomes more widely adopted, the need for larger batch sizes will ultimately conflict with the amount of available space in clean rooms. Already, there is an urgent need to produce more viral vectors per square centimeter. Corning is working to address the demand – with development efforts underway to increase yield.

Building on a long and expert history in cell culture, Corning offers viral vector manufacturing platforms, such as Corning® HYPERStack® and CellSTACK® vessels. These are easily integrated into modular production set-ups enabling viral vectors to be produced at large scales. Customized closed-system connections allow multiple vessels to be manifolded together for efficient, single-batch processing. To continue to address the demands and challenges of manufacturing adherent cells for advanced therapies, Corning has developed the new Ascent™ Fixed Bed Reactor (FBR) System, which is designed to combine the benefits of adherent bioproduction platforms with the scale and automation of suspension manufacturing systems.

相关产品

您还可能对这些相关产品感兴趣。

Cryogenic Vials

冻存管

冻存管

康宁自立式冻存管无菌、无热原,底部采用特殊设计,可以单手操作将其固定到冷冻架和冷冻盘上。

康宁自立式冻存管无菌、无热原,底部采用特殊设计,可以单手操作将其固定到冷冻架和冷冻盘上。

Erlenmeyer Flasks

锥形培养瓶

锥形培养瓶

康宁锥形培养瓶旨在提供可靠且一致的结果。

康宁锥形培养瓶旨在提供可靠且一致的结果。

Corning® Microcarriers

Corning®微载体

Corning®微载体

康宁微载体旨在简化大规模培养过程。这种无菌即用型微载体可采用封闭系统包装直接用于生物反应器。

康宁微载体旨在简化大规模培养过程。这种无菌即用型微载体可采用封闭系统包装直接用于生物反应器。

Featured Technology

Corning Ascent Fixed-Bed Bioreactor System

推动研究不断深入

推动研究不断深入

曾被视为仅在理论上可行的基因治疗,如今已经即将实现。随着基因治疗应用越来越广泛,不断加大的生产批量最终将受到洁净室空间的限制,目前亟需提高每平方厘米的病毒载体产量。康宁正在开发可提升产量的新产品,以满足此类需求。

康宁是细胞培养专家,在该领域积淀深厚,可提供多种病毒载体生产平台,如Corning® HYPERStack®超级细胞培养室 和CellSTACK® 细胞培养室。它们可以轻松整合至模块化生产设施内,实现病毒载体的大规模生产。通过定制式封闭系统连接产品,可将多个器皿连接在一起,让同一批次处理更加高效。

产品

基因治疗:特色产品

Featured Resources

Blog Series

Hear from Experts in the Field of Gene Therapy

特色技术

HYPER技术应用

基因治疗应用

特色资源

先天性失明的基因治疗

先天性失明的基因治疗

查看三位成年先天性失明患者的AAV2导入基因治疗的相关资料。

了解更多

小鼠模型中的神经保护

小鼠模型中的神经保护

了解CNTG基因治疗如何在视网膜色素变性的小鼠模型中发挥终生神经保护作用。

了解更多

支持

基因治疗应用支持